SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001341004-21-000366
Filing Date
2021-12-17
Accepted
2021-12-17 16:30:28
Documents
2
Group Members
CFIP CLYD LLCFIG CORP.FIG LLCFIP FUND II GP LLCFIP II UB INVESTMENTS LPFORTRESS OPERATING ENTITY I LPHYBRID GP HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 205662
2 EXHIBIT 3 JOINT FILING AGREEMENT ex3.htm EX-99.3 24094
  Complete submission text file 0001341004-21-000366.txt   231872
Mailing Address 1345 AVENUE OF THE AMERICAS 46TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 46TH FLOOR NEW YORK NY 10105 212-798-6100
Fortress Investment Group LLC (Filed by) CIK: 0001380393 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Subject) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90813 | Film No.: 211501964
SIC: 2834 Pharmaceutical Preparations